Hyaluronic Acid Filler Brands: How to Compare Products Safely

Hyaluronic Acid Filler Brands: How to Compare Products Safely

Juvéderm, Restylane, Teoxane RHA, and Belotero are familiar names, but a brand is not a single filler. Each family contains products with different formulations, indications, treatment areas, and labeling. Asking only “which brand do you use?” is therefore not enough: the clinical choice should be based on the exact product name, the anatomy of the area, the treatment goal, and the product's current authorization where it will be used.

In Mexico, COFEPRIS is the relevant regulator. U.S. FDA approval or European CE marking may provide context, but neither replaces Mexican registration for the exact product and presentation.

For the options available at the clinic, see information about facial harmonization treatment at Juvenalia Brío.

---

What differs between products in the same brand

Hyaluronic acid fillers contain an HA gel that is often modified or crosslinked so it remains in tissue longer. Concentration, degree of crosslinking, consistency, lidocaine content, injection depth, and approved indication can differ from one product to another.

These differences affect how a gel behaves, but they do not create a reliable ranking from “best” to “worst.” It is also inaccurate to assign one technology to an entire line. Juvéderm, for example, includes products from different technology families; one product using Vycross does not mean they all do. Likewise, lidocaine should be confirmed in the exact product name and labeling.

Common product families

This list does not imply that every product in each line is registered in Mexico or suitable for every patient.

---

How to check regulatory status in Mexico

Before treatment, ask for the full trade name and presentation. Then:

1. Search for the product in COFEPRIS's official medical-device registration records.
2. Check that the registration holder, manufacturer, and presentation match the box.
3. Ask to see the current registration number; a foreign approval is not a substitute.
4. Confirm the lot number and expiration date.
5. Make sure the syringe is sealed and opened in front of you.
6. Ask whether it came from an authorized distributor and whether the traceability label will be placed in your record.

A brand may sell different products in different countries. Presentations with similar names may also have different indications. That is why a single “FDA/COFEPRIS” checkmark for an entire brand is not reliable.

What FDA approval and CE marking mean

The FDA approves specific products for specific uses in the United States. It explains that fillers are evaluated for defined treatment areas and that approval for one area does not automatically extend to another.

CE marking belongs to the European regulatory framework; it is not FDA or COFEPRIS approval. For treatment in Mexico City, Mexican status should be checked first.

---

The product should match the treatment area

Lips

“Lip filler” is not a brand-wide indication. The exact presentation, authorized age, patient information, and Mexican registration should be checked. A product intended for the jawline, cheeks, or another area does not become suitable for lips simply because it belongs to the same family.

Jawline and chin

In the United States, Juvéderm Volux XC is indicated to improve jawline definition in adults over 21. That should not be described as a chin indication, and it should not automatically be transferred to Mexico. If that product is proposed, request the Mexican documentation for the presentation that will be used.

Under-eye or infraorbital area

The area around the eyes requires particularly careful anatomical assessment. There is no dependable rule that “the softest gel is always the safest.”

As U.S. regulatory examples, Restylane Eyelight and Belotero Balance (+) have specific indications for the infraorbital hollow. In May 2026, the FDA approved supplement P170002/S050, expanding the indication of the previously approved RHA Redensity and RHA Redensity Mepi devices to include the infraorbital region; the record names them RHA Redensity Eye Lido and RHA Redensity Eye. TEOSYAL PureSense Redensity 2 is a different product with separate documentation.

These U.S. references do not by themselves establish that the same presentation is registered or indicated in Mexico.

Skin quality and “skinboosters”

The term skinbooster is used for different products and protocols. It does not mean they all hydrate, last, or are administered in the same way.

In the United States, SKINVIVE by Juvéderm's current indication covers cheek smoothness and, since June 2026, reducing neck lines to improve neck appearance in adults over 21. Restylane Skinboosters Vital Lidocaine has manufacturer instructions describing specific treatment areas, a regimen, and maintenance for that presentation and the markets where it is supplied. Those details should not be extrapolated to a different product.

If Profhilo or another product described as a “bioremodeler” is offered, ask for its Mexican registration and local instructions before accepting concentration claims, injection-point diagrams, or a fixed number of sessions.

---

How long do results last?

There is no single duration for a brand and no universal number for each facial area. The FDA explains generally that HA filler effects are temporary and that duration depends on the material and injection site. The most useful figure is the duration in the official documentation for the exact product and exact indication.

For example, U.S. patient information for Restylane Eyelight describes effects for up to 12 months in the infraorbital hollow, while the Juvéderm Volux XC labeling reports jawline improvement through one year for most study participants. These are findings from specific products and studies, not promises for every patient or other fillers.

Be cautious with definitive claims that exercise, sun exposure, or a “fast metabolism” determines how long filler lasts. Individual response varies, and follow-up should be based on clinical change rather than a fixed commercial calendar.

---

Can every HA filler be dissolved?

Hyaluronidase is an enzyme that breaks down hyaluronic acid and may be used for certain complications or to reduce some HA fillers. Describing every filler as “completely reversible,” however, is an oversimplification:

• more than one intervention may be needed;
• response depends on the product, amount, location, and time since injection;
• assessment and treatment carry their own risks;
• the FDA notes that filler-removal effectiveness has not been studied uniformly and that removal can sometimes be difficult or impossible.

The availability of hyaluronidase does not replace careful product selection or a plan for vascular emergencies.

---

Risks and warning signs

Swelling, bruising, redness, tenderness, pain, itching, and lumps can occur after an injection. Infection, nodules, delayed inflammatory reactions, and migration have also been reported.

The most concerning complication is accidental injection into a blood vessel. It can interrupt blood flow and cause skin necrosis, visual impairment or blindness, and stroke. It is uncommon, but the harm can be permanent.

Seek immediate medical care if any of the following develops during or shortly after treatment:

• severe or unusual pain;
• white, gray, blue, mottled, or net-like skin near the area;
• blurred vision, loss of vision, or another visual change;
• one-sided weakness, trouble speaking, facial droop, confusion, severe dizziness, or sudden severe headache.

The clinician should understand the anatomy of the area, explain the risks of the exact product, and maintain a current emergency-response and referral plan.

---

Counterfeit products and needle-free devices

Do not buy fillers online or accept a syringe without intact packaging, a lot number, and traceability. The FDA warns that products sold online may be counterfeit or unapproved. COFEPRIS has also issued alerts about counterfeit Juvéderm presentations.

Devices marketed as hyaluron pens or “needle-free filler pens” are not FDA-approved for injecting dermal fillers. Pressure does not remove the risk of injury, infection, necrosis, or irregular results. Filler injection should be treated as a medical procedure performed by appropriately authorized and trained personnel.

---

A practical checklist before treatment

Ask and document:

• What is the product's full name and manufacturer?
• What is its current Mexican registration number?
• Is it indicated for this area and my age?
• May I review the patient information?
• Are the box and syringe sealed, with a visible lot number and expiration date?
• Will the traceability label be placed in my medical record?
• What training and experience does the injector have?
• What is the protocol for a vascular occlusion or visual change?
• Whom should I contact outside normal office hours?

Price, brand popularity, and social-media visibility do not answer these questions.

---